ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

Kentucky Okays Cancer Commission, $1 Million Budget

April 21, 1978

Funding opportunities listed.

October 29, 2004

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

CCIRC Fears Multimodality Studies Threatened By Cooperative Groups’ Misapplication Of Funds

January 14, 1977

New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific

October 5, 1979

In Brief: Hisserich Named USC Assistant VP, Replaced By Rideout At Cancer Center; DeVita Assures Groups

June 27, 1986